0001140361-18-024706.txt : 20180518 0001140361-18-024706.hdr.sgml : 20180518 20180518163241 ACCESSION NUMBER: 0001140361-18-024706 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180518 DATE AS OF CHANGE: 20180518 EFFECTIVENESS DATE: 20180518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clinical Ink, Inc. CENTRAL INDEX KEY: 0001496558 IRS NUMBER: 272987645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312809 FILM NUMBER: 18847082 BUSINESS ADDRESS: STREET 1: 525 VINE STREET, SUITE 130 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 BUSINESS PHONE: 336-464-0702 MAIL ADDRESS: STREET 1: 525 VINE STREET, SUITE 130 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 D 1 primary_doc.xml X0708 D LIVE 0001496558 Clinical Ink, Inc. 525 Vine Street Suite 130 Winston-Salem NC NORTH CAROLINA 27101 336-464-0702 DELAWARE None None Corporation true 2013 Edward S. Seguine, Jr. 525 Vine Street Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Executive Officer Director Roger LaVern Davenport 525 Vine Street Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Director Michael Sorensen 525 Vine Street Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Director Matthew King 525 Vine Street Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Director Richard Malcolm 525 Vine Street Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Director Other Decline to Disclose 06b false 2018-05-09 false true false 2651 Indefinite 5314013 Indefinite false 5 0 0 0 false Clinical Ink, Inc. /s/ Edward S. Seguine, Jr. Edward S. Seguine, Jr. CEO 2018-05-18